125 related articles for article (PubMed ID: 38171488)
1. Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging.
King AD; Ai QYH; Lam WKJ; Tse IOL; So TY; Wong LM; Tsang JYM; Leung HS; Zee BCY; Hui EP; Ma BBY; Vlantis AC; van Hasselt AC; Chan ATC; Woo JKS; Chan KCA
J Natl Cancer Inst; 2024 May; 116(5):665-672. PubMed ID: 38171488
[TBL] [Abstract][Full Text] [Related]
2. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.
King AD; Woo JKS; Ai QY; Chan JSM; Lam WKJ; Tse IOL; Bhatia KS; Zee BCY; Hui EP; Ma BBY; Chiu RWK; van Hasselt AC; Chan ATC; Lo YMD; Chan KCA
Ann Oncol; 2019 Jun; 30(6):977-982. PubMed ID: 30912815
[TBL] [Abstract][Full Text] [Related]
3. Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer.
Chan KCA; Lam WKJ; King A; Lin VS; Lee PPH; Zee BCY; Chan SL; Tse IOL; Tsang AFC; Li MZJ; Jiang P; Ai QYH; Poon DMC; Au KH; Hui EP; Ma BBY; Van Hasselt AC; Chan ATC; Woo JKS; Lo YMD
NEJM Evid; 2023 Jul; 2(7):EVIDoa2200309. PubMed ID: 38320164
[TBL] [Abstract][Full Text] [Related]
4. [The value of plasma EBV-DNA testing in high-risk group of nasopharyngeal carcinoma in the nasal endoscopy].
He XF; Yu X; Ji MF; Fu MY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 May; 31(10):770-773. PubMed ID: 29771040
[No Abstract] [Full Text] [Related]
5. Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma.
Liu Z; Li H; Yu KJ; Xie SH; King AD; Ai QH; Chen WJ; Chen XX; Lu ZJ; Tang LQ; Wang L; Xie CM; Ling W; Lu YQ; Huang QH; Coghill AE; Fakhry C; Pfeiffer RM; Zeng YX; Cao SM; Hildesheim A
Cancer; 2021 Sep; 127(18):3403-3412. PubMed ID: 34231883
[TBL] [Abstract][Full Text] [Related]
6. Individualized radiology screening for newly diagnosed nasopharyngeal carcinoma.
Xu Y; Xu T; Yao Q; Chen J; Hong H; Ding J; Qiu X; Chen C; Fei Z
Oral Oncol; 2024 Jun; 153():106828. PubMed ID: 38714114
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging for the detection of nasopharyngeal carcinoma.
King AD; Vlantis AC; Tsang RK; Gary TM; Au AK; Chan CY; Kok SY; Kwok WT; Lui HK; Ahuja AT
AJNR Am J Neuroradiol; 2006; 27(6):1288-91. PubMed ID: 16775281
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
[TBL] [Abstract][Full Text] [Related]
9. Detecting plasma Epstein-Barr virus DNA to diagnose postradiation nasopharyngeal skull base lesions in nasopharyngeal carcinoma patients: a prospective study.
Liang FY; Sun W; Han P; Lu X; Lian YN; Huang XM
Chin J Cancer; 2012 Mar; 31(3):142-9. PubMed ID: 22237037
[TBL] [Abstract][Full Text] [Related]
10. A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
Tay JK; Siow CH; Goh HL; Lim CM; Hsu PP; Chan SH; Loh KS
Int J Cancer; 2020 May; 146(10):2923-2931. PubMed ID: 31705522
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
12. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
13. Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
Clin Vaccine Immunol; 2009 May; 16(5):706-11. PubMed ID: 19321695
[TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
Zheng XH; Li XZ; Zhou T; Jiang CT; Tang CL; Deng CM; Liao Y; He YQ; Wang TM; Jia WH
Int J Cancer; 2023 Jun; 152(12):2629-2638. PubMed ID: 36878711
[TBL] [Abstract][Full Text] [Related]
15. Whole-Tumor Histogram and Texture Imaging Features on Magnetic Resonance Imaging Combined With Epstein-Barr Virus Status to Predict Disease Progression in Patients With Nasopharyngeal Carcinoma.
Li Q; Wang T; Huang Y; Li Q; Liu P; Grimm R; Fu C; Zhang Y; Gu Y
Front Oncol; 2021; 11():610804. PubMed ID: 33767984
[No Abstract] [Full Text] [Related]
16. Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening Programs.
Chen GH; Liu Z; Yu KJ; Coghill AE; Chen XX; Xie SH; Lin DF; Huang QH; Lu YQ; Ling W; Lin CY; Lu ZJ; Fan YY; Tang LQ; Sampson JN; Li H; King AD; Middeldorp JM; Hildesheim A; Cao SM
Clin Chem; 2022 Jul; 68(7):953-962. PubMed ID: 35325087
[TBL] [Abstract][Full Text] [Related]
17. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
Chan KC; Hung EC; Woo JK; Chan PK; Leung SF; Lai FP; Cheng AS; Yeung SW; Chan YW; Tsui TK; Kwok JS; King AD; Chan AT; van Hasselt AC; Lo YM
Cancer; 2013 May; 119(10):1838-44. PubMed ID: 23436393
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.
Chen Y; Zhao W; Lin L; Xiao X; Zhou X; Ming H; Huang T; Liao J; Li Y; Zeng X; Huang G; Ye W; Zhang Z
PLoS One; 2015; 10(7):e0132669. PubMed ID: 26151639
[TBL] [Abstract][Full Text] [Related]
19. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
20. Trans-oral brush biopsies and quantitative PCR for EBV DNA detection and screening of nasopharyngeal carcinoma.
Ng RH; Ngan R; Wei WI; Gullane PJ; Phillips J
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):602-9. PubMed ID: 24486777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]